Elon Musk's Neuralink's Surgery for Second Subject Aborted Due to Patient's Health Condition

TapTechNews June 29 - According to a report by Bloomberg today, Michael Lawton, the chief executive officer of the Barrow Neurological Institute in the US, said that the brain-computer interface company Neuralink founded by Elon Musk was originally scheduled to implant its device into the body of the second subject last Monday, but due to the patient's health condition, this surgery was forced to be aborted.

Lawton said on the phone that the health problem of the subject made him not suitable to participate in the present Neuralink's experimental device research, and at the same time, another replacement candidate may undergo surgery at the Barrow hospital next month.

He said, Selecting the right patient for such a trial is extremely important and all personnel involved in clinical and surgical operations hope to get things right. The currently cancelled patient suffers from amyotrophic lateral sclerosis, which causes the degeneration of nerve cells in the spinal cord and brain, eventually leading to muscle paralysis.

According to a previous report by TapTechNews, in May this year, the US Food and Drug Administration (FDA) approved Elon Musk's Neuralink company to implant a brain chip for the second patient and approved the repair plan proposed by the company for the problems that occurred in the first subject.

Neuralink aims to implant chips for ten people this year and hopes to have different subjects participate in order to study various behaviors. In addition, Neuralink hopes to submit applications to the regulatory authorities in Canada and the UK in the next few months to conduct similar trials.